SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615774-18-010441
Filing Date
2018-10-03
Accepted
2018-10-03 17:30:36
Documents
1
Period of Report
2018-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 s113105_form4.html 4  
1 FORM 4 s113105_form4.xml 4 3894
  Complete submission text file 0001615774-18-010441.txt   5366
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Issuer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address FALLMERAYER STR. 19 MUNICH 2M 80796
Business Address
Thomas Steffen (Reporting) CIK: 0001646396 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37606 | Film No.: 181106120